An observational study of cutaneous adverse drug reactions in a teaching hospital

被引:0
作者
Deepti Chopra
Vibha Sharma
Rohan Kapoor
Shridhar Dwivedi
机构
[1] Jamia Hamdard,Department of Pharmacology, Hamdard Institute of Medical Sciences and Research
[2] CDSCO (HQ),DGHS
[3] Jamia Hamdard,HIMSR
[4] Jamia Hamdard,Department of Medicine and Preventive Cardiology, Hamdard Institute of Medical Sciences and Research
来源
International Journal of Clinical Pharmacy | 2015年 / 37卷
关键词
ADR; Causality; Cutaneous reactions India; Maculopapular rash; Pharmacovigilance India;
D O I
暂无
中图分类号
学科分类号
摘要
Background Pharmacotherapy is often impeded by adverse drug reactions (ADRs). Among these ADRs cutaneous reactions are the major class being easily identified and reported. If not noted early it has potential to develop into serious lesions. Objective To evaluate the clinical patterns of various drug induced cutaneous reactions. Setting A Teaching hospital in India. Methods All suspected cutaneous reactions to systemic drugs which were submitted to the ADR monitoring centre during a 6-month period (March 2014–August 2014) were analysed. Causality relationship, severity assessment and preventability assessment was also done. Results Out of 134 cutaneous ADRs, 56 % occurred in females, majority of cases were found in the age group of 41–50 years. The most common type of ADR was maculopapular rash (46.3 %) and majorly implicated drug class was antibiotics (51.3 %). Most (72.3 %) were mild. Polypharmacy and multiple comorbid conditions were important predisposing factors. Over half of the cases (58 %) were not preventable. Conclusion Cutaneous adverse reaction patterns and their causes vary as the result of changing use of drugs. In India, antibiotics are responsible for the majority of the cutaneous adverse drug reactions, and maculopapular rash is the side effect that is most reported.
引用
收藏
页码:996 / 999
页数:3
相关论文
共 38 条
[1]  
Naranjo CA(1981)A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 239-245
[2]  
Busto U(1992)Preventability and severity assessment in reporting adverse drug reactions Am J Hosp Pharm 49 2229-2232
[3]  
Sellers EM(2013)The cutaneous adverse drug reactions: risk factors, prognosis and economic impacts Int J Clin Pract 67 576-584
[4]  
Sandor P(2002)Management of cutaneous drug reactions Curr Allergy Asthma Rep 2 26-33
[5]  
Ruiz I(1996)Adverse cutaneous reactions to drugs: an overview J Postgrad Med 42 15-22
[6]  
Roberts EA(2006)Adverse cutaneous drug reaction: a one year survey at a dermatology outpatient clinical of a tertiary care hospital Indian J Pharmacol 38 429-431
[7]  
Hartwig SC(2010)Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia Int J Dermatol 49 834-841
[8]  
Siegel J(2011)Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective Int J Appl Basic Med Res 1 50-53
[9]  
Schneider PJ(2002)Adverse cutaneous reactions to drugs Clin Med 2 15-19
[10]  
Liao PJ(2013)Evaluation of cutaneous drug reactions in patients visiting out patient departments of Indira Gandhi Government Medical College and Hospital (IGGMC and H), Nagpur Indian J Dermatol 58 18-21